We are live on ! Find out more
OIMU

Osmosis Investment Management UK Portfolio holdings

AUM $2.15B
This Fund
S&P 500
This Quarter Est. Return
-3%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.72B
AUM Growth
-$243M
Cap. Flow
+$7.17M
Cap. Flow %
0.19%
Top 10 Hldgs %
33.86%
Holding
499
New
131
Increased
145
Reduced
180
Closed
43

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$38.4M
2
ADI icon
Analog Devices
ADI
+$32.8M
3
MU icon
Micron Technology
MU
+$19.2M
4
SO icon
Southern Company
SO
+$18.7M
5
MDT icon
Medtronic
MDT
+$18M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$24.3M
2
NVDA icon
NVIDIA
NVDA
+$23.2M
3
AAPL icon
Apple
AAPL
+$21.2M
4
AVGO icon
Broadcom
AVGO
+$20.4M
5
LIN icon
Linde
LIN
+$17.9M

Sector Composition

Rank Sector Weight
1 Technology 32.67%
2 Financials 13.53%
3 Healthcare 11.84%
4 Communication Services 10.01%
5 Consumer Discretionary 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ILMN icon
326
Illumina
ILMN
$33.1B
$967K 0.03%
7,843
-13,862
-64% -$1.82M
STE icon
327
Steris
STE
$22.7B
$964K 0.03%
+4,359
New +$1.07M
GPN icon
328
Global Payments
GPN
$24.6B
$962K 0.03%
14,301
+11,574
+424% +$854K
CG icon
329
Carlyle Group
CG
$17.7B
$959K 0.03%
+19,812
New +$1.09M
NEE icon
330
NextEra Energy
NEE
$170B
$958K 0.03%
10,313
-45,877
-82% -$4.08M
UTHR icon
331
United Therapeutics
UTHR
$22.2B
$956K 0.03%
+1,612
New +$803K
TROW icon
332
T. Rowe Price
TROW
$23.9B
$952K 0.03%
10,563
-16,263
-61% -$1.58M
FUTU icon
333
Futu Holdings
FUTU
$17.4B
$926K 0.02%
6,770
+2,968
+78% +$461K
ABT icon
334
Abbott
ABT
$195B
$904K 0.02%
+8,806
New +$994K
LIN icon
335
Linde
LIN
$225B
$890K 0.02%
1,796
-37,963
-95% -$17.9M
DGX icon
336
Quest Diagnostics
DGX
$26.8B
$884K 0.02%
+4,509
New +$876K
STN icon
337
Stantec
STN
$8.44B
$871K 0.02%
10,098
-21,511
-68% -$2.02M
CRBG icon
338
Corebridge Financial
CRBG
$14.6B
$871K 0.02%
36,496
-10,628
-23% -$297K
IP icon
339
International Paper
IP
$20.9B
$865K 0.02%
+24,231
New +$1.01M
TXN icon
340
Texas Instruments
TXN
$236B
$860K 0.02%
+4,428
New +$897K
HUM icon
341
Humana
HUM
$46.9B
$850K 0.02%
4,878
-60,267
-93% -$12.4M
ZM icon
342
Zoom
ZM
$28.8B
$842K 0.02%
+10,477
New +$877K
PFE icon
343
Pfizer
PFE
$159B
$815K 0.02%
+29,011
New +$772K
KHC icon
344
Kraft Heinz
KHC
$30B
$807K 0.02%
35,897
-252,128
-88% -$5.93M
P
345
Everpure Inc
P
$31.2B
$796K 0.02%
13,489
-873
-6% -$59.1K
APTV icon
346
Aptiv
APTV
$9.44B
$785K 0.02%
11,307
-113,017
-91% -$8.71M
CHRW icon
347
C.H. Robinson
CHRW
$17.5B
$780K 0.02%
+4,683
New +$838K
EA
348
DELISTED
Electronic Arts
EA
$777K 0.02%
+3,813
New +$770K
LVS icon
349
Las Vegas Sands
LVS
$29.2B
$777K 0.02%
14,412
-30,278
-68% -$1.72M
APH icon
350
Amphenol
APH
$197B
$776K 0.02%
+6,132
New +$863K
12 13
14
15 16

Similar funds

VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $2.16B AUM 21.9% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $2.16B AUM 28.67% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
PMFA
Plante Moran Financial Advisors Southfield, Michigan $2.15B AUM 22.82% 1-Year Est. Return
GG
Greenwood Gearhart Fayetteville, Arkansas $2.15B AUM 25.78% 1-Year Est. Return
NM
NWI Management New York $2.16B AUM 62.95% 1-Year Est. Return

Osmosis Investment Management UK's Q1 2026 Portfolio in Review

As of Q1 2026, Osmosis Investment Management UK held 499 positions worth $3.72B, down 6.1% from $3.97B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Osmosis Investment Management UK's Q1 2026 filing shows 131 new, 145 increased, 180 reduced and 43 closed positions. Its largest new stake was AstraZeneca: 199,294 shares worth $38.6M. The largest sale was Elevance Health, an estimated $24.3M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.

  • Osmosis Investment Management UK's largest Q1 2026 buy was AstraZeneca: 199,294 shares worth $38.6M.
  • Osmosis Investment Management UK added most to Southern Company in Q1 2026, an estimated $18.7M increase.
  • Osmosis Investment Management UK's biggest Q1 2026 reduction was Elevance Health, cutting an estimated $24.3M.
  • Osmosis Investment Management UK fully exited Fortinet in Q1 2026, selling an estimated $16.1M.
  • Osmosis Investment Management UK's ten largest holdings make up 34% of its $3.72B portfolio in Q1 2026.
  • Osmosis Investment Management UK opened 131 new positions and closed 43 in Q1 2026.
  • Osmosis Investment Management UK's portfolio value fell 6.1% quarter-over-quarter to $3.72B.

Based on Osmosis Investment Management UK's 13F filing for Q1 2026, filed 14 May 2026.